Motivating persons with schizophrenia spectrum disorders to exercise: Rationale and design

Clinical Schizophrenia and Related Psychoses

Volumn 3, Issue 2, 2009, Pages 111-116

  Beebe, Lora H ^a   Burk, Renee ^a   McIntyre, Kelly B ^b   Smith, Kathlene ^c   Velligan, Dawn ^d   Resnick, Barbara ^e   Tavakoli, Abbas ^f   Tennison, Clif ^g   Dessieux, Olivera ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b InterFaith Health Clinic   (United States)

^c and Fellow Transcultural Nursing Society Scholars   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e UNIVERSITY OF BALTIMORE   (United States)

^f UNIVERSITY OF SOUTH CAROLINA   (United States)

^g Helen Ross McNabb Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BEHAVIOR CHANGE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION MAKING; EXERCISE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; NUTRITIONAL COUNSELING; OBESITY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SCORING SYSTEM; WALKING; WEIGHT CONTROL;

EID: 70349260448     PISSN: 19351232     EISSN: None     Source Type: Journal    
DOI: 10.3371/CSRP.3.2.6     Document Type: Article

References (38)

1. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington, DC, American Psychiatric Association, 2000.
2. Kopelowicz A, Ventura J, Liberman RP, Mintz J. Consistency of Brief Psychiatric Rating Scale factor structure across a broad spectrum of schizophrenia patients. Psychopathology 2008;41(2):77-84. (Pubitemid 350308306)
3. Premkumar P, Cooke MA, Fannon D, Peters E, Michel TM, Aasen I, et al. Misattribution bias of threat-related facial expression is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder. Eur Psychiatry 2008;23(1):14-19.
4. Sacchetti F, Galluzzo A, Panariello A, Parrinello G, Cappa SF. Self-ordered pointing and visual conditioning associated learning tasks in drug-free schizophrenia spectrum disorder patients. BMC Psychiatry 2008;8:6. (Pubitemid 351279971)
5. Fleischhacker WW, Cetkovick-Bakmas M, De Hert M, Hennekens CH, Lambert M, Leucht S, et al. Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy and research challenges. J Clin Psychiatry 2008;69(4):514-519. (Pubitemid 351792324)
6. Ananth J, Venkatesh R, Burgoyne K, Gadasalli R, Binford R, Gunatilake S. Atypical antipsychotic induced weight gain: pathophysiology and management. Ann Clin Psychiatry 2004;16(2):75-85. (Pubitemid 39070973)
7. Jin H, Meyer JM, Jeste DV. Atypical antipsychotics and glucose dysregulation: a systematic review. Schizophr Res 2004;71(2-3):195-212. (Pubitemid 39330499)
8. Newcomer JW. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs. J Clin Psychiatry 2004;65 Suppl 18:36-46.
9. Gimino FA, Levin SJ. The effects of aerobic exercise on perceived self-image in post-hospitalized schizophrenic patients. Medicine and Science in Sports and Exercise 1984;16:139.
10. Chamove AS. Positive short-term effects of activity on behaviour in chronic schizophrenic patients. Br J Clin Psychol 1986;25(Pt 2):125-133. (Pubitemid 16111322)
11. Pelham TW, Campagna PD, Ritvo PG, Birnie WA. The effects of exercise therapy on clients in a psychiatric rehabilitation program. Psychosocial Rehabilitation Journal 1993;16:75-84.
12. Beebe LH, Tian L, Morris N, Goodwin A, Allen SS, Kuldau J. Effects of exercise on mental and physical health parameters of persons with schizophrenia. Issues Ment Health Nurs 2005;26(6):661-676. (Pubitemid 41022038)
13. Pendlebury J, Haddad P, Dursun S. Evaluation of a behavioral weight management programme for patients with severe mental illness: 3 year results. Hum Psychopharmacol 2005;20(6):447-448. (Pubitemid 41269703)
14. Ball MP, Coons VB, Buchanan RW. A program for treating olanzapine-related weight gain. Psychiatr Serv 2001;52(7):967-969.
15. Vreeland B, Minsk S, Menza M, Rigassio Radler D, Roemheld-Hamm B, Stern R. A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv 2003;54(8):1155-1157. (Pubitemid 36951518)
16. Archie S, Wilson JH, Osborne S, Hobbs H, McNiven J. Pilot study: access to fitness facility and exercise levels in olanzapine-treated patients. Can J Psychiatry 2003;48(9):628-632. (Pubitemid 37429468)
17. Menza M, Vreeland B, Minsky S, Gara M, Radler DR, Sakowitz M. Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program. J Clin Psychiatry 2004;65(4):471-477.
18. Resnick B. Efficacy beliefs in geriatric rehabilitation. J Gerontol Nurs 1998;24(7):34-44.
19. Resnick B. Testing a model of exercise behavior in older adults. Res Nurs Health 2001;24(2):83-92. (Pubitemid 33604340)
20. Resnick B. Testing the effect of the WALC intervention on exercise adherence in older adults. J Gerantol Nurs 2002;28(6):40-49.
21. Resnick B, Orwig D, Magaziner J, Wynne C. The effect of social support on exercise behavior in older adults. Clin Nurs Res 2002;11(1):52-70.
22. Resnick B, Palmer MH, Jenkins LS, Spellbring AM. Path analysis of efficacy expectations and exercise behavior in older adults. J Adv Nurs 2000;31(6):1309-1315.
23. Resnick B, Spellbring AM. Understanding what motivates older adults to exercise. J Gerantol Nurs 2000;26(3):34-42.
24. Dishman RK. Increasing and maintaining exercise and physical activity. Behavior Therapy 1991;22:345-373.
25. Resnick B. Across the aging continuum: motivating older adults to exercise. Adv Nurse Pract 2005;13(9):37-40.
26. Mann MJ, Pruitt RH, Meehan NK, Kemper KH. Get moving. Counseling seniors about physical activity. Adv Nurse Pract 1997;5(7):36-40, 73.
27. Alexopoulos GS, Kiosses DN, Heo M, Murphy CF, Shanmugham B, Gunning- Dixon F. Executive dysfunction and the course of geriatric depression. Biol Psychiatry 2005;58(3):204-210. (Pubitemid 41112268)
28. Kiosses DN, Alexopoulos GS. IADL function, cognitive deficits, and severity of depression: a preliminary study. Am J Geriatr Psychiatry 2005;13(3):244-249.
29. Velligan DI, Bow-Thomas CC. Executive function in schizophrenia. Semin Clin Neuropsychiatry 1999;4(1):24-33.
30. Bowie CR, Jaga K. Methods for treating cognitive deficits in schizophrenia. Expert Rev Neurother 2007;7(3):281-287. (Pubitemid 46434176)
31. Bilder RM, Reiter G, Bates J, Lencz T, Szeszko P, Goldman RS, et al. Cognitive development in schizophrenia: follow-back from the first episode. J Clin Exp Neuropsychol 2006;28(2):270-282. (Pubitemid 43254519)
32. Seidman LJ, Buka SL, Goldstein JM, Tsuang MT. Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study. J Clin Exp Neuropsychol 2006;28(2):225-242.
33. Vaskinn A, Sundet K, Frits S, Simonsen C, Birkenaes AB, Jonsdottir H, et al. Emotion perception and learning potential: mediators between neurocognition and social problem solving in schizophrenia? J Int Neuropsychol Soc 2008;14(2):279-288.
34. Bacon E, Izaute M, Danion JM. Preserved memory monitoring but impaired memory control during episodic encoding in patients with schizophrenia. J Int Neuropsychol Soc 2007;13(2):219-227. (Pubitemid 46487353)
35. Kim H, Lee D, Shin YM, Chey J. Impaired strategic decision making in schizophrenia. Brain Res 2007;1180:90-100.
36. Beebe LH. Walking tall: a person with schizophrenia on a journey to better health. J Psychosoc Nurs Ment Health Serv 2005;44(6):53-55.
37. Velligan DI, Kern RS, Gold JM. Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies. Schizophr Bull 2006;32(3):474-485.
38. Reid JG, Thomson JM. Exercise prescription for fitness. Englewood Cliffs (NJ): Prentice-Hall; 1985.